Local News Matters on MSN
New era in cancer treatment: UCSF scientist wins $1 million for KRAS breakthrough
A researcher at the University of California, San Francisco, has won a $1 million prize for an advance in cancer treatment, the medical school said. Kevan Shokat, a chemical biologist, was honored ...
NewsNation on MSN
Your Morning: Potential cancer breakthrough revealed
View online. YOUR MORNING November 26, 2025 Good morning, NewsNation. For more fact-based, unbiased news coverage 24/7 – Download the NewsNation app here > NewsNation ‘Killing Cancer’ special reveals ...
Merck and Moderna’s success with a personalized cancer vaccine designed to keep melanoma at bay opens a new avenue of treatment that doctors hope will work against many types of tumors. Unlike ...
Add Yahoo as a preferred source to see more of our stories on Google. A new technique to fight solid tumors could change the way cancer is treated, researchers believe. CAR-T cell therapy has been a ...
Add Yahoo as a preferred source to see more of our stories on Google. The FDA gave the green light to a new cancer treatment being researched at HonorHealth in Scottsdale. The pill, Daraxonrasib, ...
Treatment for leukemia, lymphoma, myeloma and other blood cancers is changing quickly. More targeted immune therapies, increasingly sophisticated stem cell transplants and gentler approaches to ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new targeted treatment for pancreatic cancer has been approved by the FDA after impressive ...
Intermountain Health oncologists say a new medication just approved by the U.S. Food and Drug Administration appears to be a breakthrough in the treatment of ...
Daraxonrasib, a drug developed by Dana-Farber Cancer Institute, works by blocking the specific gene mutations thought to drive abnormal cell growth in pancreatic cancer. The treatment has shown so ...
ImmunityBio (IBRX) stock fell 7.25% to $9.27 despite ANKTIVA trial results showing a 71% response rate and lasting benefits ...
Dame Deborah James would have been "thrilled" by the results of a new study which has found a way to stop late-stage bowel cancer cells from growing. The late cancer campaigner and podcast host passed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results